Antitachycardia pacing for reduction of implantable cardioverter-defibrillator shocks
- PMID: 25708880
- DOI: 10.1016/j.hrthm.2015.02.024
Antitachycardia pacing for reduction of implantable cardioverter-defibrillator shocks
Abstract
Antitachycardia pacing (ATP) strategies represent safe, effective, and painless therapy for ventricular tachyarrhythmias, with a large body of clinical evidence supporting their routine use in both primary and secondary implantable cardioverter-defibrillator recipients. This article details the evidence supporting the use of standardized and validated ATP strategies for primary prevention patients and the conceptual framework to design effective ATP strategy for secondary prevention patients.
Keywords: Antitachycardia pacing; Implantable cardioverter-defibrillator; Sudden cardiac death.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical